.png){kind=icon}
.png){kind=icon}
Return
Targeting the Hallmarks of Ageing: Pharmacological Challenges and Breakthroughs in CRISPR Delivery Systems and Future Prospects
.png){kind=icon}
PRE
AI
S
A
K
N
S
DOI：10.1016/j.arr.2026.103301.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• CRISPR technologies can target the biological hallmarks of ageing. • Reviews current advances in viral, non-viral, and nanotechnology-based CRISPR delivery systems. • Discusses the pharmacological and translational challenges limiting clinical application. • Identifies future prospects of converting CRISPR-based therapies into healthy aging treatments.
Journal
IF:
12.4
Papers:
3.5K
Citations:
2.3W
Organization
Cited Papers